Based on the potential value of the revenue stream for LymPro an up front cash payment in excess of $15,000,000 would be reasonable accompanied by additional milestone payments.
Becton Dickinson for LymPro or Novartis for MANF for diabetes.
Buy a few shares of AMBS and hold them for a year.
Up listing to the NASDAQ in 2014.
Wait to buy below $2.00 in a few days.
"AMBS" - Market Cap of $27M
Zack's analyst, Jason Napadano, says it's a "BUY" and worth $90M currently.
In deal with Becton Dickinson to develop its test to detect early stage Alzheimer's. It's patented drug,MANF, could be worth billions.
Currently under a dime.
"Please let there be someone dumber than me who will buy my Barrick shares for more than I paid for them so that I can put the money back in the savings account before the wife finds out."
Recently moved into the bio-tech incubator, Janssen Labs, which is sponsored by JNJ. Read the recent Yahoo news.
The one stock to buy today for substantial upside in 2014. Currently trading under a dime with a market cap of $28M.
Zack's: Buy Rating
Of course it's possible to short AMBS. Anyone who says it isn't possible is somewhat ignorant. Why do you think AMBS put a "no shorting" clause in its funding agreement?
"AMBS" - Read the recent Yahoo news. If you missed the run up on GERN don't miss it on AMBS.
Buy a few shares under a dime and hold them for six months.